“…At concentrations that induce no changes in haemo‐dynamics or creatinine clearance, agmatine as well as the I 1 ‐ligands moxonidine, clonidine and 2,6‐dimethyl‐clonidine increase urinary flow‐rate, whereby agmatine first shows significant changes at ∼10 fold higher doses ( Allan et al ., 1993 ; Li et al ., 1994b ; Ernsberger et al ., 1995 ; Penner & Smyth, 1996 ). The increase in urinary flow under moxonidine, 2,6‐dimethylclonidine and agmatine results from an increased osmotic clearance, while under clonidine it is due to an increased clearance of free water, consistent with the imidazoline‐mediated inhibition of the Na + /H + ‐exchange in isolated renal tubular cells ( Bidet et al ., 1990 ). This suggests that the osmotic clearance is possibly an imidazoline binding site‐mediated effect, but that free water clearance might be due to an α 2 ‐receptor‐related mechanism ( Smyth & Penner, 1995 ), since compared to clonidine the relative affinities of agmatine, moxonidine and dimethyl clonidine are higher for imidazoline binding sites than they are for α 2 ‐adrenoceptors ( Ernsberger et al ., 1995 ).…”